Home > News > Nanotech Zeroes in on the Pharmaceutical Industry
March 9th, 2006
Nanotech Zeroes in on the Pharmaceutical Industry
Abstract:
Jack Uldrich: I am in Dallas today speaking to the AmericansourceBergen Specialty Group about nanotechnology and its implications for the pharmaceutical sector. Therefore my mind has been focused on pharmaceutical applications for the past few days. Two recent developments have caught my attention and they could have implications for nanotech investors.
Source:
NanoNovus
Bookmark:
Investments/IPO's/Splits
Elsevier Business Intelligence (EBI) to Host 'IN3 Medical Device 360 Boston,' June 24-26, 2013 May 20th, 2013
Aspen Aerogels Announces $22.5 Million Private Placement May 18th, 2013
Harris & Harris Group Notes the Sale of a Second D-Wave Quantum Computer May 16th, 2013
Nanometrics Announces Upcoming Investor Events May 14th, 2013
Announcements
Competition in the Quantum World May 20th, 2013
Elsevier Business Intelligence (EBI) to Host 'IN3 Medical Device 360 Boston,' June 24-26, 2013 May 20th, 2013
Penn engineers' nanoantennas improve infrared sensing May 20th, 2013
Researchers Perform Fastest Measurements Ever Made of Ion Channel Proteins May 20th, 2013